Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Rating of "Moderate Buy" from Analysts

Key Points

• Sabra Healthcare REIT, Inc. has received a consensus rating of "Moderate Buy" from seven analysts, with an average target price of $20.00.
• The company recently reported $0.38 EPS for the quarter, exceeding expectations of $0.36, and had a revenue of $189.15 million versus projected $185.64 million.
• Sabra Healthcare REIT declared a quarterly dividend of $0.30 per share, reflecting a yield of 6.2%, with a payout ratio of 157.89%.

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight research firms that are covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $20.2857.

Several analysts have issued reports on the company. Scotiabank increased their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. JMP Securities increased their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Finally, BMO Capital Markets increased their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Nomura Holdings Inc. increased its position in Sabra Healthcare REIT by 24.0% during the 2nd quarter. Nomura Holdings Inc. now owns 15,236 shares of the real estate investment trust's stock valued at $281,000 after buying an additional 2,949 shares in the last quarter. Headlands Technologies LLC acquired a new position in Sabra Healthcare REIT during the 2nd quarter valued at about $511,000. CANADA LIFE ASSURANCE Co increased its position in Sabra Healthcare REIT by 0.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 273,952 shares of the real estate investment trust's stock valued at $5,058,000 after buying an additional 1,710 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Sabra Healthcare REIT by 213.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 41,770 shares of the real estate investment trust's stock valued at $770,000 after buying an additional 28,448 shares in the last quarter. Finally, Captrust Financial Advisors increased its position in Sabra Healthcare REIT by 20.4% during the 2nd quarter. Captrust Financial Advisors now owns 60,371 shares of the real estate investment trust's stock valued at $1,113,000 after buying an additional 10,235 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Trading Down 0.3%

NASDAQ:SBRA traded down $0.06 during midday trading on Thursday, hitting $19.19. The stock had a trading volume of 2,596,504 shares, compared to its average volume of 2,781,370. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $4.60 billion, a price-to-earnings ratio of 25.25, a PEG ratio of 1.53 and a beta of 0.86. The stock has a 50-day moving average of $18.49 and a 200 day moving average of $17.73. Sabra Healthcare REIT has a one year low of $15.60 and a one year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. The business had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts forecast that Sabra Healthcare REIT will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.